SCHEMBL2433176

SCHEMBL2433176

COC(=O)C1CCC(OC(F)(C(=O)Cc2cc(Cl)c(Nc3nc4ccccc4o3)cc2F)N2CCCC2)CC1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ITGB1 P05556 10/20 0.43
ITGA4 P13612 10/20 0.43
RORC P51449 1/20 0.40
MAPT P10636 4/20 0.36
USP2 O75604 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
ALDH1A1 P00352 3/20 0.36
TSHR P16473 3/20 0.36
KDM4E B2RXH2 1/20 0.36
MEN1 O00255 1/20 0.36
POLB P06746 1/20 0.36
PKM P14618 1/20 0.36
KMT2A Q03164 1/20 0.36
HSD17B10 Q99714 1/20 0.36
NPC1 O15118 1/20 0.35
RAB9A P51151 1/20 0.35
SSTR5 P35346 1/20 0.35
LMNA P02545 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.34
GALK1 P51570 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2433175 1.00 ITGB1 (0.43) ITGB1ITGA4RORCMAPTUSP2
SCHEMBL2433229 0.93 ITGB1 (0.50) ITGB1ITGA4RORCNPC1RAB9A
SCHEMBL2433230 0.93 ITGB1 (0.50) ITGB1ITGA4RORCNPC1RAB9A
SCHEMBL2436085 0.89 ITGA4 (0.53) ITGB1ITGA4RORCMAPTUSP2
SCHEMBL2436082 0.89 ITGA4 (0.53) ITGB1ITGA4RORCMAPTUSP2
SCHEMBL2432072 0.86 ITGB1 (0.42) ITGB1ITGA4RORCMAPTUSP2
SCHEMBL2437763 0.85 ITGB1 (0.54) ITGB1ITGA4RORCMAPTALDH1A1
SCHEMBL2437765 0.85 ITGB1 (0.54) ITGB1ITGA4RORCMAPTALDH1A1
SCHEMBL2436149 0.84 ITGA4 (0.45) ITGB1ITGA4RORCMAPTUSP2
SCHEMBL2436146 0.84 ITGA4 (0.45) ITGB1ITGA4RORCMAPTUSP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1346982-B1 VLA-4 INHIBITORS DAIICHI SEIYAKU CO (JP) 2011-09-14 EP disclosed
US-7157487-B2 Vla-4 inhibitors DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2007-01-02 US disclosed
US-20040110945-A1 Vla-4 inhibitors DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2004-06-10 US disclosed
EP-1346982-A1 VLA-4 INHIBITORS DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2003-09-24 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040110945-A1 Vla-4 inhibitors VCAM1, ITGA1, ITGB4 ITGB1 5/4885ITGA4 4/4885RORC 675/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.